# Zhejiang Chempacific Corporation – FDA Inspection, Mar 23, 2018

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-chempacific-corporation/38852223-11ec-436f-a575-a301a1e77434
Source feed: FDA_Inspections

> FDA inspection 1050336 of Zhejiang Chempacific Corporation, March 23, 2018. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050336
- Company Name: Zhejiang Chempacific Corporation
- Inspection Date: 2018-03-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1268222 - 2025-04-04](https://www.keypedia.com/records/fda_inspections/zhejiang-chempacific-corporation/c08e1ac6-317f-4265-be3d-a9c1e7be2bf2)
- FDA Inspection 896936 - 2014-09-04
- FDA Inspection 728751 - 2011-05-06

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/tiara-n-brown-crosen/8255649d-25a9-49fa-a28d-0cdda922c0c3)

Company: https://www.keypedia.com/companies/zhejiang-chempacific-corporation/d7e48883-0d85-4d70-a1be-e96379589a1f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c